期刊文献+

1648例孕中期母血清产前筛查结果分析 被引量:1

Analysis of prenatal screening 1648 cases in mid-pregnant women
下载PDF
导出
摘要 目的:评估血清标志物甲胎蛋白(Alpha-fetoprotein,AFP)和游离绒毛膜促性腺激素(Free-βHCG)在孕中期进行先天缺陷疾病筛查的价值和作用。方法:用酶联免疫法对孕妇血清AFP和free-βHCG进行检测,并结合孕妇年龄、孕周、体重等因素,采用配套软件估算风险概率。结果:在3299例孕中期妇女中,唐氏综合征、18-三体综合征和神经管缺陷高危筛查阳性率分别为7.16%、0.61%和2.37%。经细胞遗传学分析1例确诊为唐氏综合征,另外2例经超声检查证实为神经管缺陷。结论:孕中期母血清二联(AFP,free-βHCG)检查是有效安全的产前筛查方法,有利于降低先天性缺陷婴儿的出生率。 Objective:To assess the value and impact of screening programme in mid-pregnancy women for the congenital fet abnormality that uses the two maternal serum markers:α-fetoprotein(AFP)and freeβhuman chorionic gonadotrophin(free-βHCG) Methods:Serum screening of AFP and free-βHCG were offered to the 14~20 weeks pregnant Measuring the serum AFP and free βHCGin pregnant women with ELISA,and combined with other factors:age,weeks of pregnancy,weight,etc.Measuring the high ri rate with special software.Results:Within 1 648 cases of women in the mid-pregnancy,Down's syndrom,18-trisomysyndrome an neural tube defect high risk rates in screen were 7.16%,0.61%and 2.37%respectively.1 case was confirm the Down's syndrome analysis of cytogenetics,another 2 cases was diagnosed neural tube defect via ultrasonography.Conclusion:the second trimester doub test would be effective and safe screening strategies and could be used to decrease natality of congenital fetal malformation
作者 张于勤
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第4期639-640,共2页 Journal of Chongqing Medical University
关键词 唐氏综合征 神经管缺陷 18-三体综合征 产前筛查 Down's syndrome Nerual tube defect 18-trisomysyndrome Prenatal screening
  • 相关文献

参考文献13

  • 1张迅.唐氏综合征的孕期筛查[J].中国实用妇科与产科杂志,2002,18(9):522-524. 被引量:39
  • 2Filly.The best way to terify a pregnant[J].Ultrasound Med,2000,19 (6):1.
  • 3Wald N J,Densem J W,Smith D,et al.Four-marker serum screening for Down's syndrome[J].Prenat Diagn,1994,14(8):707.
  • 4Morris J k.Wald N J.Estimating the risk of Down' s syndrome in antenatal screeningandthe gestation at which this risk applies[J].Med Screen,2007,14(l):5.
  • 5Merkatz I R,Nitowski H M,Macri J N,et al.An association between low maternal serum a-fetoproteinand fetal chromosomal abnormalities[J].AmJ Obstet Gynecol,1984,148(5):886.
  • 6Baumgarten A,Schoenfeld M,Mahoney M J,et al.Prospective screening for Down syndrome using maternal serum AFP[J].Lancet,1985,2(1):1280.
  • 7Fuhrmann W,Wendt P.Weitzel HK Maternal serum-AFP screening test for Down syndrome[J].Lancet,1985,39(4):751.
  • 8Haddow J E,Palomaki G E,Wald N J.Collaborative study of Down syndromescreening using maternal serum alpha-fetoproteinscreening and maternal age[J].Lancet,1986,2(8521-22):1460.
  • 9Bogart M H,Pandian M R,Jones O W.Abnormal maternalserum chorionic gonadotrophin levels in pregnancies with fetal chromosome abnormalities[J].Prenat Diagn,1987,7(9):623.
  • 10Canick J A,Knight G J,Palomaki G E,et al.Low second trimester maternal serumunconjugated oestriol in pregnancies with Down syndrome[J].Obstet Gynaecol,1988,95(4):330.

二级参考文献1

共引文献38

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部